Frontiers in Endocrinology,
Journal Year:
2022,
Volume and Issue:
13
Published: May 4, 2022
Pharmacomicrobiomics
refers
to
the
interactions
between
foreign
compounds
and
gut
microbiome
resulting
in
heterogeneous
efficacy,
side
effects,
toxicity
of
compound
concerned.
Glucose
lowering
drugs
reduce
blood
glucose
by
modulating
insulin
secretion
its
actions
as
well
redistributing
energy
disposal.
Apart
from
genetic,
ecological,
lifestyle
factors,
maintaining
an
equilibrium
whole
has
been
shown
improve
human
health.
Microbial
fingerprinting
using
faecal
samples
indicated
‘invisible
phenotype’
due
different
compositions
microbiota
which
might
orchestrate
patients’
phenotypes
their
responses
glucose-lowering
drugs.
In
this
article,
we
summarize
current
evidence
on
differences
composition
individuals
with
type
2
diabetes
(T2D)
healthy
individuals,
disruption
balance
beneficial
pathogenic
was
patients
T2D
how
Western
Medicine
(WM)
Traditional
Chinese
(TCM)
re-shape
benefits
host
immunity
metabolic
We
particularly
highlighted
effects
both
WM
TCM
increase
relative
abundance
health
promoting
bacteria,
such
as,
Akkermansia
muciniphila
,
Blautia,
Bifidobacterium
adolescentis
have
implicated
(T2D).
Several
lines
suggested
that
complement
efficacy
through
alteration
warrants
further
investigation
our
pursuit
prevention
control
T2D.
World Journal of Gastroenterology,
Journal Year:
2024,
Volume and Issue:
30(22), P. 2852 - 2865
Published: June 5, 2024
Diabetes,
commonly
known
for
its
metabolic
effects,
also
critically
affects
the
enteric
nervous
system
(ENS),
which
is
essential
in
regulating
gastrointestinal
(GI)
motility,
secretion,
and
absorption.
The
development
of
diabetes-induced
neuropathy
can
lead
to
various
GI
dysfunctions,
such
as
gastroparesis
irregular
bowel
habits,
primarily
due
disruptions
function
neuronal
glial
cells
within
ENS,
well
oxidative
stress
inflammation.
This
editorial
explores
pathophysiological
mechanisms
underlying
diabetic
patients.
Additionally,
it
discusses
latest
advances
diagnostic
approaches,
emphasizing
need
early
detection
intervention
mitigate
complications
individuals.
reviews
current
emerging
therapeutic
strategies,
focusing
on
pharmacological
treatments,
dietary
management,
potential
neuromodulatory
interventions.
Ultimately,
this
highlights
necessity
a
multidisciplinary
approach
managing
diabetes,
aiming
enhance
patient
quality
life
address
frequently
overlooked
complication
widespread
disease.
Scientific Reports,
Journal Year:
2024,
Volume and Issue:
14(1)
Published: Aug. 1, 2024
Abstract
The
gut
and
oral
microbiome
is
altered
in
people
living
with
HIV
(PLWH).
While
antiretroviral
treatment
(ART)
pivotal
restoring
immune
function
PLWH,
several
studies
have
identified
an
association
between
specific
antiretrovirals,
particularly
integrase
inhibitors
(INSTI),
weight
gain.
In
our
study,
we
explored
the
differences
microbiota
of
PLWH
under
different
ART
regimens,
its
correlation
to
Body
Mass
Index
(BMI).
Fecal
salivary
samples
were
collected
from
(n
=
69)
healthy
controls
(HC,
n
80).
We
performed
taxonomy
analysis
determine
microbial
composition
relationship
abundance
BMI,
CD4
+
T-cell
count,
CD4/CD8
ratio,
duration.
showed
significantly
lower
richness
compared
HC
both
environment.
INSTI-treated
individuals
was
enriched
Faecalibacterium
Bifidobacterium
,
whereas
non-nucleotide
reverse
transcriptase
inhibitor
(NNRTI)-treated
Gordonibacter
Megasphaera,
Staphylococcus
.
microenvironment,
Veillonella
more
abundant
Fusobacterium
Alloprevotella
NNRTI-treated
individuals.
Furthermore,
Dorea
milieu
high
BMI.
Collectively,
findings
identify
distinct
profiles,
which
are
associated
regimens
BMI
on
successful
ART,
thereby
highlighting
significant
effects
antiretrovirals
microbiome.
Advanced Science,
Journal Year:
2022,
Volume and Issue:
9(28)
Published: Aug. 17, 2022
Abstract
Membranous
nephropathy
(MN)
is
a
common
cause
of
nephrotic
syndrome.
The
aim
to
establish
non‐invasive
diagnostic
model
MN
using
differential
gut
microbiome
analysis,
and
explore
the
relationship
between
pathogenesis
in
vivo.
825
fecal
samples
from
patients
healthy
participants
are
collected
multiple
medical
centers
across
China.
Key
operational
taxonomic
units
(OTUs)
obtained
through
16S
rRNA
sequencing
used
model.
A
rat
developed
MN.
diversity
richness
significantly
lower
with
than
individuals.
based
on
seven
OTUs
achieves
an
excellent
efficiency
98.36%
training
group
also
high
cross‐regional
cohorts.
In
model,
elimination
prevents
establishment,
but
transplantation
restores
phenotype
protein
urine.
Gut
analysis
can
be
as
tool
for
diagnosis.
onset
depends
presence
naturally
colonized
microbiome.
Early
intervention
may
help
reduce
urinary
level
Frontiers in Microbiology,
Journal Year:
2023,
Volume and Issue:
14
Published: July 12, 2023
Background
Gut
microbiota,
particularly
Oxalobacter
formigenes
,
has
been
previously
reported
to
be
associated
with
kidney
stones.
However,
the
conflicting
results
from
both
observational
and
intervention
studies
have
created
substantial
uncertainty
regarding
contribution
of
formation
stone.
Methods
We
employed
a
two-sample
MR
analysis
investigate
causal
relationship
between
gut
microbiota
stones
using
GWASs
summary
statistics
obtained
MiBioGen
FinnGen
consortia.
Moreover,
we
conducted
reserve
assess
direction
associations
The
inverse
variance
weighted
(IVW)
approach
represents
primary
method
Mendelian
Randomization
(MR)
analysis.
Results
Our
analyses
do
not
yield
supportive
evidence
for
link
genus
Oxalobacte
r
(OR
=
0.99,
95%
CI:
0.90–1.09,
p
0.811)
order
Actinomycetales
0.79,
0.65–0.96,
0.020),
family
Actinomycetaceae
0.019),
Clostridiaceae
1
0.80,
0.67–0.96,
0.015),
Clostridiumsensustricto
0.81,
0.67–0.98,
0.030)
Hungatella
0.86,
0.74–0.99,
0.040)
had
protective
effects
on
stones,
Haemophilus
1.16,
1.01–1.33,
0.032),
Ruminococcaceae
(UCG010)
1.38,
1.04–1.84,
0.028),
Subdoligranulum
1.27,
1.06–1.52,
0.009)
were
risk
factors
Differential
abundance
provide
no
association
showed
Reverse
did
indicate
any
microbiota.
No
considerable
heterogeneity
instrumental
variables
or
horizontal
pleiotropy
was
observed.
Conclusion
study
find
does
solely
depend
presence
/
.
A
more
integrated
multiple
omics
platforms
is
needed
better
understand
pathogenesis
in
context
complex
gene–environment
interactions
over
time.
Frontiers in Endocrinology,
Journal Year:
2022,
Volume and Issue:
13
Published: Oct. 11, 2022
Objective
Excessive
carbohydrate
intake
is
a
high
risk
factor
for
increased
morbidity
of
type
2
diabetes
(T2D).
A
novel
regimen
the
dietary
care
that
consists
highly
active
α-amylase
inhibitor
derived
from
white
common
bean
extract
(WCBE)
and
sufficient
carbohydrates
was
applied
to
attenuate
T2D
its
complications.
Furthermore,
role
gut
microbiota
in
this
remission
also
investigated.
Methods
We
conducted
4-month
randomized
double-blinded
placebo-controlled
trial.
During
intense
intervention
period,
ninety
subjects
were
randomly
assigned
control
group
(Group
C)
WCBE
W).
Subjects
Group
C
supplemented
with
1.5
g
maltodextrin
as
placebo.
W
took
half
an
hour
before
meal.
Fifty-five
participants
continued
maintenance
receiving
previous
whereas
less
frequent
follow-up.
The
variation
biochemical,
vasculopathy
neuropathy
indicators
structure
fecal
during
analyzed.
Result
Glucose
metabolism
diabetic
complications
showed
superior
0.721
±
0.742%
decline
glycosylated
hemoglobin
after
4
months.
proportion
patients
peripheral
(Toronto
Clinical
Scoring
System,
TCSS
≥
6)
significantly
lower
than
C.
Both
left
right
sural
sensory
nerve
conduction
velocity
(SNCV-left
SNCV-right
sural)
slightly
decreased
W.
Additionally,
abundances
Bifidobacterium
,
Faecalibacterium
Anaerostipes
higher
W,
Weissella
Klebsiella
Cronobacter
Enterobacteriaceae_unclassified
those
at
month
2.
At
end
4,
remained
more
abundant
Conclusion
To
our
knowledge,
first
report
improvement
by
using
supplement
such
short-term
period.
enrichment
SCFA-producing
bacteria
might
be
responsible
attenuation
trial
registration
number
http://www.chictr.org.cn/edit.aspx?pid=23309&htm=4
identifier
ChiCTR-IOR-17013656
Frontiers in Cellular and Infection Microbiology,
Journal Year:
2025,
Volume and Issue:
15
Published: May 6, 2025
The
complex
interrelation
of
gut
microbiota
with
human
health
underlines
the
profound
influence
this
microbial
ecosystem
has
on
mechanisms
disease
and
wellness.
microbiome
profoundly
impacts
various
diseases,
encompassing
gastrointestinal
disorders,
metabolic
neurological
immune-related
diseases.
Gastrointestinal
disorders
are
closely
linked
to
imbalances
in
gut.
Metabolic
including
obesity
type
2
diabetes,
influenced
by
microbiota's
role
energy
regulation
glucose
metabolism.
Furthermore,
gut-brain
axis
highlights
correlation
between
conditions
such
as
Alzheimer's
Parkinson's.
Moreover,
assumes
a
pivotal
function
regulating
immune
system,
whereby
dysbiosis
is
implicated
developing
immunological-related
ailments,
allergies
autoimmune
disorders.
Predisposing
factors,
diet,
medicines,
lifestyle,
environmental
influences,
described
having
an
important
composition
microbiome.
By
understanding
these
we
can
get
valuable
insights
into
how
intervene
reduce
chances
disease.
Current
interventions,
probiotics,
prebiotics,
fecal
transplants,
lifestyle
modification,
show
promise,
but
there
still
challenges
unanswered
questions
evolving
field
that
may
lead
improvements.
This
review
interrelates
complicated
mechanisms,
predisposing
potential
interventions.